Fierce Pharma October 11, 2024
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a deal is indeed brewing.
Sanofi has entered negotiations with private equity outfit Clayton, Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in its consumer health business, dubbed Opella, the company said Friday.
Sanofi has pledged to offer updates on the potential transaction “in due course, when a decision is made.”
France-based Opella employs more than 11,000 people across 100 countries. The company operates 13 manufacturing sites and four research and innovation centers, Sanofi said in a release.
As the world’s third-largest firm in over-the-counter vitamins, minerals and supplements, Opella also markets popular household brands like allergy med Allegra, Icy...
Today's Sponsors
Today's Sponsor